OQS
ODT

Occudo Quantitative Strategies’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Occudo Quantitative Strategies’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,609
Closed -$33K – 1410
2021
Q4 		$33K Buy
24,609
+1,338
+6% +$3.16K ﹤0.01% 1025
2021
Q3 		$68K Sell
23,271
-17,939
-44% -$59.6K 0.01% 955
2021
Q2 		$144K Sell
41,210
-127,988
-76% -$439K 0.02% 763
2021
Q1 		$579K Buy
169,198
+141,160
+503% +$2.67M 0.13% 282
2020
Q4 		$538K Buy
+28,038
New +$433K 0.17% 222

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Occudo Quantitative Strategies's ODT Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 24,609 shares — an estimated $33K sold.

Occudo Quantitative Strategies first reported a position in ODT in Q4 2020 and held it in 5 quarters. The position peaked at $579K in Q1 2021. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 24,609 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $33K.
  • Occudo Quantitative Strategies first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Odonate Therapeutics, Inc. Common Stock position peaked at $579K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.